Sterling Pharma Solutions

Cramlington, United Kingdom
ADC Bioconjugation HPAPI/Small Molecule API Peptides Linker-Payload Synthesis
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (10) ○ EMA GMP ○ MHRA GMP

Quick Facts: Sterling Pharma Solutions

Signal Score
60.0/100
Quality Compliance
Assessment pending
Headquarters
Cramlington, United Kingdom
Modalities
ADC, Bioconjugation, HPAPI/Small Molecule API, Peptides, Linker-Payload Synthesis
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Sterling Pharma Solutions

Auto-created by AI matchmaker. Data verification pending.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesADC, Bioconjugation, HPAPI/Small Molecule API, Peptides, Linker-Payload Synthesis
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 60.0
Broad modality coverage (5 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (5 modalities)

Recent News 10 articles

news Wed, 03 Ap
CDMO Sterling burnishes its U.S. credentials with buyout of North Carolina facility - Fierce Pharma
Source →
news Wed, 02 Ma
Novartis sells pair of manufacturing plants as Sandoz strategic review rolls on - Fierce Pharma
Source →
news Tue, 25 Ja
Sterling Pharma Solutions expands early phase development - Manufacturing Chemist
Source →
news Tue, 04 Oc
CDMO Sterling Pharma Solutions created from MBO of U.K. facility - Fierce Pharma
Source →
news Thu, 25 Ma
GHO Capital and Partners Group invest in Sterling Pharma - GlobeNewswire
Source →
news Thu, 13 Ju
The CDMO/CMO Report: High-Potency API Manufacturing - DCAT Value Chain Insights
Source →
news Thu, 08 Fe
ADC handling: the whole story of a facility startup - Cleanroom Technology
Source →
news Thu, 01 Oc
CDMO Sterling Pharma continues buying spree with former Alcami ingredients plant pickup - Fierce Pharma
Source →
news Fri, 31 Ma
Sterling Pharma Solutions to Invest $3 Million in Germantown, WI Plant - Pharmaceutical Commerce
Source →
news Fri, 17 Oc
Cabaletta corrals cell therapy Legend—Chutes & Ladders - Fierce Biotech
Source →

Frequently Asked Questions About Sterling Pharma Solutions

What is Sterling Pharma Solutions's CDMO Signal Score?
Sterling Pharma Solutions has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Sterling Pharma Solutions for a manufacturing program?
Use the free AI matchmaker to compare Sterling Pharma Solutions against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
ADC CDMOs → Bioconjugation CDMOs → HPAPI/Small Molecule API CDMOs → Linker-Payload Synthesis CDMOs →

Similar CDMOs

Abzena
San Diego, CA; Bristol, PA; Cambridge, UK
Signal Score: 64.0
ADC, AOC, RDC, PDC, DAC, Fusion Proteins, Bispecifics, bsAbs, Multispecifics, msAbs, Bioconjugates, Biologics, mAb, Monoclonal Antibody, Antibodies, Cytokines, HPAPI, Bioconjugation
Sai Life Sciences
Hyderabad, India
Small Molecule API, Complex Small Molecules, HPAPI, ADC, Peptides, Oligonucleotides, Lipids / LNP, Intermediates, Drug Discovery (CRO)
Cerbios-Pharma
Lugano, Switzerland
ADC, HPAPI, Bioconjugation, Biologics, Oligonucleotides
Biopharma Group
Swindon, United Kingdom
Sterile Injectable Fill-Finish, HPAPI/Cytotoxics, ADC, Biologics, Lyophilization
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC